Hep B Blog

Category Archives: Liver Cancer

HBV Journal Review – June 2015

ChrisKHBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the
 latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored:

  • HBV Liver Cancer Requires Aggressive Treatment from the Start
  • Experts: Treat Cirrhotic Patients, Even if Viral Load Is Low
  • Some Patients Can Safely Stop Antiviral After Four Years
  • Tenofovir Safe and Effective in Pregnant Women with Drug Resistance
  • Researchers Discover Why Children Become Chronically Infected
  • Expert Recommends Treatment for Mental Confusion from Cirrhosis
  • Antivirals Increase Survival After Liver Cancer Treatment
  • HBV Patients with Diabetes Have a Higher Risk of Liver Cancer
  • Long-term Antiviral Use Increases Hip Fracture Rates Slightly
  • Second Vaccine Series May Be Needed for Children with Celiac Disease
  • Researchers Find HBV B Strain in Cuba Did Not Come from Africa

Continue reading "HBV Journal Review – June 2015"

Support Services for Families Facing Liver Cancer Webinar

What support services are available for patients and families that are facing liver cancer? Are there any assistance programs to help pay for treatment or other costs? What about online or community support?

Listen to this webinar from the Hepatitis B Foundation’s Liver Cancer Connect program. Guest speakers Karla Pillote, a nurse practitioner at Johns Hopkins’ Sibley Memorial Hospital in Washington DC, and Andrea Wilson, founder of BlueFaery: The Adrienne Wilson Liver Cancer Association, explain how families can access valuable services.

Be sure to visit Liver Cancer Connect for all you need to know about liver cancer!

Clinical Trials Webinar -What YOU need to know!

Why do we have clinical trials? What is involved with clinical trial participation? How do I find a trial that’s right for me? Find out by listening to this webinar from Liver Cancer Connect, a dedicated program of the Hepatitis B Foundation. Presenters Jill McNair of the Center for Information & Study on Clinical Research Participation, and Katelyn Levy, BS, clinical research coordinator at Johns Hopkins Suburban Hospital, explain what clinical trials are and answer frequently asked questions about participating in a trial.

Continue reading "Clinical Trials Webinar -What YOU need to know!"

Q & A – Treatment Options for Liver Cancer Webinar

gish_robert_garethDr. Gish answered answered a number of very important questions for those diagnosed with liver cancer, and also has some great advice for liver cancer surveillance, including best imaging tests for the diagnosis of cirrhosis or liver cancer and more.  Continue reading "Q & A – Treatment Options for Liver Cancer Webinar"

May is Asian Pacific American Heritage Month

moon-anncart-logo-for-blog-300x180In celebration of Asian Pacific Heritage Month, Dr. moon Chen, Principal Investigator for the Asian American Network for Cancer Awareness Research and Training (AANCART) and UC Davis professor, reflects on the unnecessary cancer burden in Asian American and Pacific Islanders, including the burden of  hepatitis B related liver cancer.  Continue reading "May is Asian Pacific American Heritage Month"

Clinical Trials in Liver Cancer: What You Need to Know

diversegroupMyth: Clinical trials are only for people with advanced stages of cancer.

Fact: No! Trials are available for all stages of cancer, not just for people who have advanced cancer that is not responding to treatment.

If you or a loved one needs treatment for liver cancer, clinical trials are an option to think about. Continue reading "Clinical Trials in Liver Cancer: What You Need to Know"

Webinar on Treatment Options for Liver Cancer: What You Need to Know

 

gish_robert_gareth

Please join the Hepatitis B Foundation’s Liver Cancer Connect program and world-renowned liver disease specialist, Dr. Robert Gish for a webinar on Monday, April 27th 12 noon EDT to learn about liver cancer treatment. How does the stage of the cancer affect treatment? Why are screening and surveillance so important? What are the available treatments and what are the therapies in development? Continue reading "Webinar on Treatment Options for Liver Cancer: What You Need to Know"

Slaying the Fibrolamellar Beast

 

Fibrolamellar Chimera- Slay the Beast
The chimera mutation is common to all fibrolamellar tissue. The mythological chimera is part lion, part goat, and part serpent. Original Chimera illustration by Jessica Guercia Design by Deborah Corrigan Visual Arts | DeborahCorriganVA.com.

February 28 is Rare Disease Day.

Last year, we featured the story of Gail Trecosta, who described how her teenage son Matthew was bravely battling a rare form of liver cancer called fibrolamellar hepatocellular carcinoma (FHC).

This year we are featuring FHC again but with a renewed sense of urgency and purpose.  Continue reading "Slaying the Fibrolamellar Beast"